Ramelteon
Back to searchMolecule Structure
Scientific Name
Ramelteon
Description of the Drug
Ramelteon is a melatonin receptor agonist used to treat insomnia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00980
http://www.drugbank.ca/drugs/DB00980
Brand Name(s)
Ramelteon, Rozerem
Company Owner(s)
Enaltec Labs Inc, Takeda Pharmaceuticals Usa Inc, Actavis Laboratories Fl Inc, Dr Reddys Laboratories Sa, I3 Pharmaceuticals Llc, Granules Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Appco Pharma Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Melatonin receptor | PROTEIN FAMILY | AGONIST | CHEMBL2094268 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL29237 | |
| PharmGKB | PA164744896 | |
| Human Metabolome Database | HMDB0015115 | |
| DrugBank | DB00980 | |
| PubChem: Thomson Pharma | 14823708 | 14847999 |
| PubChem | 208902 | |
| LINCS | LSM-20965 | |
| Nikkaji | J1.473.195D | |
| PDBe | JEV | |
| BindingDB | 50118470 | |
| DrugCentral | 2355 | |
| ChemicalBook | CB0496858 | |
| Guide to Pharmacology | 1356 | |
| rxnorm | RAMELTEON | ROZEREM |
| PubChem: Drugs of the Future | 12015157 | |
| ChEBI | 109549 | |
| ZINC | ZINC000003960338 |
